Clinical Trial Update: Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating immunotherapies in combination with stereotactic body radiotherapy for microsatellite stable metastatic colorectal cancer has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Microsatellite-stable Colorectal Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Microsatellite Stable Metastatic Colorectal Cancer, Metastatic Colorectal Cancer | Phase 2 | Status: WITHDRAWN